183 related articles for article (PubMed ID: 38643738)
21. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease.
Huang Y; Wang X; Zhang L; Zheng K; Xiong J; Li J; Cong C; Gong Z; Mao J
Comput Math Methods Med; 2022; 2022():7888076. PubMed ID: 35677177
[TBL] [Abstract][Full Text] [Related]
22. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang LL; Zhang PH; Yan HH
Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
[TBL] [Abstract][Full Text] [Related]
23. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
Front Nutr; 2022; 9():880014. PubMed ID: 35669067
[TBL] [Abstract][Full Text] [Related]
24. Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: A systematic review and network meta-analysis.
Tan-Lim CSC; Esteban-Ipac NAR; Recto MST; Castor MAR; Casis-Hao RJ; Nano ALM
Pediatr Allergy Immunol; 2021 Aug; 32(6):1255-1270. PubMed ID: 33811784
[TBL] [Abstract][Full Text] [Related]
25. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Wang ST; Zheng J; Peng HW; Cai XL; Pan XT; Li HQ; Hong QZ; Peng XE
BMC Gastroenterol; 2020 Mar; 20(1):66. PubMed ID: 32164541
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
27. The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis.
Li S; Liu J; Wang Z; Duan F; Jia Z; Chen X; Li S
Front Public Health; 2022; 10():862266. PubMed ID: 35958869
[TBL] [Abstract][Full Text] [Related]
28. Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis.
Wang X; Jin X; Li H; Zhang X; Chen X; Lu K; Chu C
Front Pharmacol; 2023; 14():1180016. PubMed ID: 37063273
[No Abstract] [Full Text] [Related]
29. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
30. A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial.
Kobyliak N; Abenavoli L; Mykhalchyshyn G; Kononenko L; Boccuto L; Kyriienko D; Dynnyk O
J Gastrointestin Liver Dis; 2018 Mar; 27(1):41-49. PubMed ID: 29557414
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Zhang T; Zhang C; Zhang J; Sun F; Duan L
Front Cell Infect Microbiol; 2022; 12():859967. PubMed ID: 35433498
[TBL] [Abstract][Full Text] [Related]
32. Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate.
Liang Y; Lin C; Zhang Y; Deng Y; Liu C; Yang Q
Inflammopharmacology; 2018 Aug; 26(4):1051-1055. PubMed ID: 29633106
[TBL] [Abstract][Full Text] [Related]
33. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.
Ebrahimi-Mousavi S; Alavian SM; Sohrabpour AA; Dashti F; Djafarian K; Esmaillzadeh A
BMC Gastroenterol; 2022 Mar; 22(1):102. PubMed ID: 35255811
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Fan S; Shi X; Yao J; Zhong M; Feng P
Rev Esp Enferm Dig; 2020 Aug; 112(8):627-635. PubMed ID: 32496108
[TBL] [Abstract][Full Text] [Related]
35. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials.
Zheng HJ; Guo J; Wang Q; Wang L; Wang Y; Zhang F; Huang WJ; Zhang W; Liu WJ; Wang Y
Crit Rev Food Sci Nutr; 2021; 61(4):577-598. PubMed ID: 32329633
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yu X; Wang Y; Lai J; Song T; Duan J
Ir J Med Sci; 2023 Feb; 192(1):131-142. PubMed ID: 35366201
[TBL] [Abstract][Full Text] [Related]
39. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW.
Chaves FGB; Oliveira GF; Ribeiro JP; Serafim JV; Cordeiro LFM; Alvares MA; Cecchi MT; Vasquez MC; Souza TBD; Rullo VEV
Rev Paul Pediatr; 2021; 39():e2019226. PubMed ID: 32876312
[TBL] [Abstract][Full Text] [Related]
40. Which is the best probiotic treatment strategy to prevent the necrotizing enterocolitis in premature infants: A network meta-analysis revealing the efficacy and safety.
Bi LW; Yan BL; Yang QY; Li MM; Cui HL
Medicine (Baltimore); 2019 Oct; 98(41):e17521. PubMed ID: 31593123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
